Literature DB >> 20488634

BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants.

Savina Mannarino1, Francesca Garofoli, Elisa Mongini, Rosa Maria Cerbo, Alessia Claudia Codazzi, Chryssoula Tzialla, Iolanda Mazzucchelli, Gianfranco Perotti, Carmine Tinelli, Annalisa De Silvestri, Paolo Manzoni, Mauro Stronati.   

Abstract

To evaluate and compare cardiovascular adaptation of 36 preterm and 34 fullterm newborns, we analyzed BNP concentration and echocardiographic parameters at day 3 of life and at day 28 (+/-2). On day 3 BNP concentrations (pg/ml) resulted higher in PDA preterm group (n=11; 125, IQR 56.1-301) than preterm without PDA (n=25; 25.5 IQR 10.9-49; p<0.001) than fullterms (n=34; 55.1 IQR 23.6-82.7; p=0.013). No difference resulted in all groups at 28days (respectively: 12.7 IQR 4.9-23.8; 15.6 IQR 10-22; 8.9 IQR 5.6-20.6). Because of the newborns' growth, all echocardiographic parameters increased with linear relationship with body weight. On day 3 BNP concentration and echocardiographic parameters were not correlated besides LA/AO in preterms with PDA (p=0.0015). On day 28, BNP was significantly correlated with mVTI (p=0.019), M (p=0.007) and LA (p=0.005) in fullterms and only with LA (p=0.007) in preterms. In conclusion, BNP concentrations and echocardiographic measures confirm that preterm, and fullterm newborns conduct themselves in a similar manner during the transition from foetal to post-natal circulation, reaching low levels at a month of life. The presence of PDA during first days of life has no significant impact in this adaptation. LA is the echocardiographic parameter mostly related to BNP concentration in the newborns. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488634     DOI: 10.1016/j.earlhumdev.2010.04.003

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  9 in total

1.  NT-proBNP as an Early Marker of Diastolic Ventricular Dysfunction in Very-Low-Birth-Weight Infants.

Authors:  Pamela Zafra-Rodríguez; Paula Méndez-Abad; Simón P Lubián-López; Isabel Benavente-Fernández
Journal:  Pediatr Cardiol       Date:  2019-06-07       Impact factor: 1.655

2.  The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants.

Authors:  K König; K J Guy; G Walsh; S M Drew; A Watkins; C P Barfield
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

3.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

Review 4.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

5.  Prenatal Particulate Matter (PM) Exposure and Natriuretic Peptides in Newborns from Mexico City.

Authors:  Abigail Muñoz-Rodríguez; Jorge Alfonso Maciel-Ruiz; Ana María Salazar; Monserrat Sordo; Patricia Ostrosky-Wegman; Jorge H Limón-Pacheco; Andrés Eduardo Nepomuceno-Hernández; Rodrigo Ayala-Yáñez; María Eugenia Gonsebatt; Citlalli Osorio-Yáñez
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

6.  [B-type brain natriuretic peptide as marker of hemodynamic overload of the patent ductus arteriosus in the preterm infant].

Authors:  J Rafael Parra-Bravo; M Teresa Valdovinos-Ponce; Heladia García; Juan C Núñez-Enríquez; M Lourdes Jiménez-Cárdenas; Rodrigo Avilés-Monjaraz; Wendy Lavana-Hernández
Journal:  Arch Cardiol Mex       Date:  2020-11-03

Review 7.  Cardiac Biomarkers in Pediatrics: An Undervalued Resource.

Authors:  Mary Kathryn Bohn; Shannon Steele; Alexandra Hall; Jasmin Poonia; Benjamin Jung; Khosrow Adeli
Journal:  Clin Chem       Date:  2021-07-06       Impact factor: 12.167

8.  B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: a prospective, multicentre, cross-sectional study.

Authors:  David Rodriguez; Gerardo Garcia-Rivas; Estibalitz Laresgoiti-Servitje; Jesus Yañez; Guillermo Torre-Amione; Carlos Jerjes-Sanchez
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

Review 9.  Application of B-Type Natriuretic Peptide in Neonatal Diseases.

Authors:  Haotai Xie; Yixuan Huo; Qinzheng Chen; Xinlin Hou
Journal:  Front Pediatr       Date:  2021-12-07       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.